BREAST CANCER DRUG APPROVED FOR USE

Following negotiations with manufacturer Roche, Welsh Labour's Health Secretary Vaughan Gething has announced that breast cancer drug Kadcyla®, will be routinely available on the Welsh NHS.

Roche has now agreed with NHS Wales the same commercial access agreement as NHS England. This means that Welsh patients with certain types of advanced breast cancer will be able to benefit from the treatment.

The Welsh Labour Government’s £80 million New Treatment Fund has been designed to ensure new medicines such as Kadcyla® can be made available as soon as possible, and certainly within two months of the recommendation from NICE.

 


Volunteer Facebook Twitter

Contact us / Cysylltwch â Ni

Stay in touch / Cadwch mewn Cysylltiad